Annie Mayence & Jean Jacques Vanden Eynde. (2019). Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus Kinases. MDPI AG.
Chicago Style (17th ed.) CitationAnnie Mayence and Jean Jacques Vanden Eynde. Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus Kinases. MDPI AG, 2019.
MLA (9th ed.) CitationAnnie Mayence and Jean Jacques Vanden Eynde. Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus Kinases. MDPI AG, 2019.
Warning: These citations may not always be 100% accurate.